L-PRP/L-PRF in esthetic plastic surgery, regenerative medicine of the skin and chronic wounds

Current Pharmaceutical Biotechnology

Volumn 13, Issue 7, 2012, Pages 1266-1277

  Cieslik Bieleck, Agata ^a   Choukroun, Joseph ^b   Odin, Guillaume ^c   Dohan Ehrenfest, David M ^d  

^a MEDICAL UNIVERSITY OF SILESIA   (Poland)

^b Pain Clinic Center   (France)

^c UNIVERSITÉ CÔTE D'AZUR   (France)

^d Chonnam National University   (South Korea)

Author keywords

Blood platelet; Fibrin; Growth factors; Plastic surgery; Platelet rich fibrin (PRF); Platelet rich plasma (PRP); Regenerative medicine; Wound healing

Indexed keywords

AMINOCAPROIC ACID; ANTIBIOTIC AGENT; APROTININ; BIOMATERIAL; BLOOD CLOTTING FACTOR 12; BLOOD CLOTTING FACTOR 13; CALCIUM CHLORIDE; FIBRIN; FIBRIN GLUE; FIBROBLAST GROWTH FACTOR; GROWTH FACTOR; INTERLEUKIN 1; LEUKOCYTE AND PLATELET RICH FIBRIN; PLATELET DERIVED GROWTH FACTOR; RECOMBINANT GROWTH FACTOR; THROMBIN; THROMBOCYTE CONCENTRATE; TRANEXAMIC ACID; TRANSFORMING GROWTH FACTOR ALPHA; TRANSFORMING GROWTH FACTOR BETA; TUMOR NECROSIS FACTOR; UNCLASSIFIED DRUG;

ARTICLE; CELL MIGRATION; CELL PROLIFERATION; CHRONIC WOUND; CLINICAL RESEARCH; DEBRIDEMENT; DIABETIC FOOT; ESTHETIC SURGERY; HEMATOMA; HEMOSTASIS; HISTOPATHOLOGY; HUMAN; IMMUNOHISTOCHEMISTRY; IN VITRO STUDY; IN VIVO STUDY; LEUKOCYTE AND PLATELET RICH PLASMA; LEUKOCYTE COUNT; LEUKOCYTE TRANSFUSION; MAXILLOFACIAL SURGERY; MEDIATOR; NONHUMAN; POSTOPERATIVE HEMORRHAGE; POSTOPERATIVE PAIN; PROTEIN FUNCTION; RANDOMIZED CONTROLLED TRIAL (TOPIC); REGENERATIVE MEDICINE; SKIN; SKIN GRAFT; SKIN INJURY; SKIN ULCER; SURGICAL TECHNIQUE; SURGICAL WOUND; SUTURING METHOD; THROMBOCYTE RICH PLASMA; TISSUE ADHESION; TISSUE REPAIR; VASODILATATION; WOUND DRESSING; WOUND HEALING;

EID: 84861145257     PISSN: 13892010     EISSN: 18734316     Source Type: Journal    
DOI: 10.2174/138920112800624463     Document Type: Article

References (115)

1. Dohan Ehrenfest, D.M.; Rasmusson, L.; Albrektsson, T. Classification of platelet concentrates: from pure platelet-rich plasma (PPRP) to leucocyte-and platelet-rich fibrin (L-PRF). Trends Biotechnol., 2009, 27(3), 158-167.
2. Matras, H. Die Wirkungen vershiedener Fibrinpraparate auf Kontinuitat-strennungen der Rattenhaut. Osterr. Z. Stomatol., 1970, 67(9), 338-359.
3. Knighton, D.R.; Ciresi, K.; Fiegel, V.D.; Schumerth, S.; Butler, E.; Cerra, F. Stimulation of repair in chronic, nonhealing, cutaneous ulcers using platelet-derived wound healing formula. Surg. Gynecol. Obstet., 1990, 170(1), 56-60.
4. Knighton, D.R.; Ciresi, K.F.; Fiegel, V.D.; Austin, L.L.; Butler, E.L. Classification and treatment of chronic nonhealing wounds. Successful treatment with autologous platelet-derived wound healing factors (PDWHF). Ann. Surg., 1986, 204(3), 322-330.
5. Knighton, D.R.; Doucette, M.; Fiegel, V.D.; Ciresi, K.; Butler, E.; Austin, L. The use of platelet derived wound healing formula in human clinical trials. Prog. Clin. Biol. Res., 1988, 266, 319-329.
6. Gibble, J.W.; Ness, P.M. Fibrin glue: the perfect operative sealant? Transfusion, 1990, 30(8), 741-747.
7. Matras, H. The use of fibrin sealant in oral and maxillofacial surgery. J. Oral Maxillofac. Surg., 1982, 40(10), 617-622.
8. Clark, R.A. Fibrin and wound healing. Ann. N.Y. Acad. Sci., 2001, 936, 355-367.
9. van Hinsbergh, V.W.; Collen, A.; Koolwijk, P. Role of fibrin matrix in angiogenesis. Ann. N.Y. Acad. Sci., 2001, 936, 426-437.
10. Dohan, D.M.; Choukroun, J.; Diss, A.; Dohan, S.L.; Dohan, A.J.; Mouhyi, J.; Gogly, B. Platelet-rich fibrin (PRF): a secondgeneration platelet concentrate. Part I: technological concepts and evolution. Oral Surg. Oral Med. Oral Pathol. Oral Radiol. Endod., 2006, 101(3), e37-44.
11. Marx, R.E.; Carlson, E.R.; Eichstaedt, R.M.; Schimmele, S.R.; Strauss, J.E.; Georgeff, K.R. Platelet-rich plasma: Growth factor enhancement for bone grafts. Oral Surg. Oral Med. Oral Pathol. Oral Radiol. Endod., 1998, 85(6), 638-646.
12. Whitman, D.H.; Berry, R.L.; Green, D.M. Platelet gel: an autologous alternative to fibrin glue with applications in oral and maxillofacial surgery. J. Oral Maxillofac. Surg., 1997, 55(11), 1294-1299.
13. Man, D.; Plosker, H.; Winland-Brown, J.E. The use of autologous platelet-rich plasma (platelet gel) and autologous platelet-poor plasma (fibrin glue) in cosmetic surgery. Plast. Reconstr. Surg., 2001, 107(1), 229-237.
14. Dohan Ehrenfest, D.M.; Bielecki, T.; Del Corso, M.; Inchingolo, F.; Sammartino, G. Shedding light in the controversial terminology for platelet-rich products: Platelet-Rich Plasma (PRP), Platelet-Rich Fibrin (PRF), Platelet-Leukocyte Gel (PLG), Preparation Rich in Growth Factors (PRGF), classification and commercialism. J. Biomed. Mater. Res. A., 2010, 95(4), 1280-1282.
15. Bielecki, T.; Gazdzik, T.S.; Szczepanski, T. Re: "The effects of local platelet rich plasma delivery on diabetic fracture healing". What do we use: Platelet-rich plasma or platelet-rich gel? Bone, 2006, 39(6), 1388.
16. Everts, P.A.; van Zundert, A.; Schonberger, J.P.; Devilee, R.J.; Knape, J.T. What do we use: platelet-rich plasma or plateletleukocyte gel? J. Biomed. Mater. Res. A., 2008, 85(4), 1135-1136.
17. Cieslik-Bielecka, A.; Gazdzik, T.S.; Bielecki, T.M.; Cieslik, T. Why the platelet-rich gel has antimicrobial activity? Oral Surg. Oral Med. Oral Pathol. Oral Radiol. Endod., 2007, 103(3), 303-305.
18. Bielecki, T.; Gazdzik, T.S.; Szczepanski, T. Benefit of percutaneous injection of autologous platelet-leukocyte-rich gel in patients with delayed union and nonunion. Eur. Surg. Res., 2008, 40(3), 289-296.
19. Bielecki, T.M.; Gazdzik, T.S.; Arendt, J.; Szczepanski, T.; Krol, W.; Wielkoszynski, T. Antibacterial effect of autologous platelet gel enriched with growth factors and other active substances: an in vitro study. J. Bone Joint Surg. Br., 2007, 89(3), 417-420.
20. Everts, P.A.; Devilee, R.J.; Brown Mahoney, C.; van Erp, A.; Oosterbos, C.J.; Stellenboom, M.; Knape, J.T.; van Zundert, A. Exogenous application of platelet-leukocyte gel during open subacromial decompression contributes to improved patient outcome. A prospective randomized double-blind study. Eur. Surg. Res., 2008, 40(2), 203-210.
21. Everts, P.A.; Hoffmann, J.; Weibrich, G.; Mahoney, C.B.; Schonberger, J.P.; van Zundert, A.; Knape, J.T. Differences in platelet growth factor release and leucocyte kinetics during autologous platelet gel formation. Transfus. Med., 2006, 16(5), 363-368.
22. Everts, P.A.; Overdevest, E.P.; Jakimowicz, J.J.; Oosterbos, C.J.; Schonberger, J.P.; Knape, J.T.; van Zundert, A. The use of autologous platelet-leukocyte gels to enhance the healing process in surgery, a review. Surg. Endosc., 2007, 21(11), 2063-2068.
23. Moojen, D.J.; Everts, P.A.; Schure, R.M.; Overdevest, E.P.; van Zundert, A.; Knape, J.T.; Castelein, R.M.; Creemers, L.B.; Dhert, W.J. Antimicrobial activity of platelet-leukocyte gel against Staphylococcus aureus. J. Orthop. Res., 2008, 26(3), 404-410.
24. Cieslik-Bielecka, A.; Bielecki, T.; Gazdzik, T.S.; Arendt, J.; Krol, W.; Szczepanski, T. Autologous platelets and leukocytes can improve healing of infected high-energy soft tissue injury. Transfus. Apher. Sci., 2009, 41(1), 9-12.
25. Dohan Ehrenfest, D.M.; Coelho, P.G.; Kang, B.S.; Sul, Y.T.; Albrektsson, T. Classification of osseointegrated implant surfaces: materials, chemistry and topography. Trends Biotechnol., 2010, 28(4), 198-206.
26. Mishra, A.; Pavelko, T. Treatment of chronic elbow tendinosis with buffered platelet-rich plasma. Am. J. Sports Med., 2006, 34(11), 1774-1778.
27. Mishra, A.; Woodall, J., Jr.; Vieira, A. Treatment of tendon and muscle using platelet-rich plasma. Clin. Sports Med., 2009, 28(1), 113-125.
28. Dohan Ehrenfest, D.M.; Del Corso, M.; Diss, A.; Mouhyi, J.; Charrier, J.B. Three-dimensional architecture and cell composition of a choukroun's platelet-rich fibrin clot and membrane. J. Periodontol., 2010, 81(4), 546-555.
29. Bayerlein, T.; Proff, P.; Fanghanel, J.; Kauschke, E.; Rumpel, E.; Gerike, W.; Bienengraber, V.; Gedrange, T. Wound management after the application of bone grafting substitutes in the orofacial region. Folia Morphol. (Warsz.), 2006, 65(1), 89-91.
30. Del Frari, B.; Schoeller, T.; Wechselberger, G. Reconstruction of large head and neck deformities: experience with free gracilis muscle and myocutaneous flaps. Microsurgery, 2010, 30(3), 192-198.
31. Hosseini, S.V.; Bananzadeh, A.M.; Rivaz, M.; Sabet, B.; Mosallae, M.; Pourahmad, S.; Yarmohammadi, H. The comparison between drainage, delayed excision and primary closure with excision and secondary healing in management of pilonidal abscess. Int. J. Surg., 2006, 4(4), 228-231.
32. Guo, S.; Dipietro, L.A. Factors affecting wound healing. J. Dent. Res., 2010, 89(3), 219-229.
33. Altman, R.; Scazziota, A.; de Lourdes Herrera, M.; Gonzalez, C.D. The hemostatic profile of recombinant activated factor VII. Can low concentrations stop bleeding in off-label indications? Thromb. J., 2010, 8, 8.
34. Naimushin, Y.A.; Mazurov, A.V. Role of glycoprotein IIb-IIIa (alpha IIb beta 3-integrin) in stimulation of secretion from platelet granules. Biochemistry (Mosc.), 2003, 68(2), 209-216.
35. Kalb, M.L.; Potura, L.; Scharbert, G.; Kozek-Langenecker, S.A. The effect of ex vivo anticoagulants on whole blood platelet aggregation. Platelets, 2009, 20(1), 7-11.
36. Shin, J.; Ji, S.; Choi, Y. Ability of oral bacteria to induce tissuedestructive molecules from human neutrophils. Oral Dis., 2008, 14(4), 327-334.
37. Barrientos, S.; Stojadinovic, O.; Golinko, M.S.; Brem, H.; Tomic-Canic, M. Growth factors and cytokines in wound healing. Wound Repair Regen., 2008, 16(5), 585-601.
38. Moali, C.; Hulmes, D.J. Extracellular and cell surface proteases in wound healing: new players are still emerging. Eur. J. Dermatol., 2009, 19(6), 552-564.
39. Grazul-Bilska, A.T.; Johnson, M.L.; Bilski, J.J.; Redmer, D.A.; Reynolds, L.P.; Abdullah, A.; Abdullah, K.M. Wound healing: the role of growth factors. Drugs Today (Barc.), 2003, 39(10), 787-800.
40. Werner, S.; Krieg, T.; Smola, H. Keratinocyte-fibroblast interactions in wound healing. J. Invest. Dermatol., 2007, 127(5), 998-1008.
41. Bruck, H.G. Fibrin tissue adhesion and its use in rhytidectomy: a pilot study. Aesthetic Plast. Surg., 1982, 6(4), 197-202.
42. Bhanot, S.; Alex, J.C. Current applications of platelet gels in facial plastic surgery. Facial Plast. Surg., 2002, 18(1), 27-33.
43. Brittberg, M.; Sjogren-Jansson, E.; Lindahl, A.; Peterson, L. Influence of fibrin sealant (Tisseel) on osteochondral defect repair in the rabbit knee. Biomaterials, 1997, 18(3), 235-242.
44. Achauer, B.M.; Miller, S.R.; Lee, T.E. The hemostatic effect of fibrin glue on graft donor sites. J. Burn Care Rehabil., 1994, 15(1), 24-28.
45. Blomback, B. Studies on fibrinogen: its purification and conversion into fibrin. Acta Physiol. Scand. Suppl., 1958, 43(148), 1-51.
46. Blomback, B.; Hessel, B.; Hogg, D.; Therkildsen, L. A two-step fibrinogen--fibrin transition in blood coagulation. Nature, 1978, 275(5680), 501-505.
47. Greenberg, C.S.; Miraglia, C.C.; Rickles, F.R.; Shuman, M.A. Cleavage of blood coagulation factor XIII and fibrinogen by thrombin during in vitro clotting. J. Clin. Invest., 1985, 75(5), 1463-1470.
48. Campbell, R.A.; Overmyer, K.A.; Selzman, C.H.; Sheridan, B.C.; Wolberg, A.S. Contributions of extravascular and intravascular cells to fibrin network formation, structure, and stability. Blood, 2009, 114(23), 4886-4896.
49. Lorand, L.; Velasco, P.T.; Murthy, S.N.; Lefebvre, P.; Green, D. Autoimmune antibody in a hemorrhagic patient interacts with thrombin-activated factor XIII in a unique manner. Blood, 1999, 93(3), 909-917.
50. Marchac, D.; Sandor, G. Face lifts and sprayed fibrin glue: an outcome analysis of 200 patients. Br. J. Plast. Surg., 1994, 47(5), 306-309.
51. Oliver, D.W.; Hamilton, S.A.; Figle, A.A.; Wood, S.H.; Lamberty, B.G. A prospective, randomized, double-blind trial of the use of fibrin sealant for face lifts. Plast. Reconstr. Surg., 2001, 108(7), 2101-2105.
52. Fezza, J.P.; Cartwright, M.; Mack, W.; Flaharty, P. The use of aerosolized fibrin glue in face-lift surgery. Plast. Reconstr. Surg., 2002, 110(2), 658-664.
53. Byrne, D.J.; Hardy, J.; Wood, R.A.; McIntosh, R.; Cuschieri, A. Effect of fibrin glues on the mechanical properties of healing wounds. Br. J. Surg., 1991, 78(7), 841-843.
54. Clevens, R.A.; Prendiville, S. Reflections on aesthetic facial surgery in men. Facial Plast. Surg. Clin. North Am., 2009, 17(4), 613-624, vii.
55. Rosenthal, A.R.; Egbert, P.R.; Harbury, C.; Hopkins, J.L.; Rubenstein, E. Use of platelet-fibrinogen-thrombin mixture to seal experimental penetrating corneal wounds. Albrecht Von Graefes Arch. Klin. Exp. Ophthalmol., 1978, 207(2), 111-115.
56. Rosenthal, A.R.; Harbury, C.; Egbert, P.R.; Rubenstein, E. Use of a platelet-fibrinogen-thrombin mixture as a corneal adhesive: experiments with sutureless lamellar keratoplasty in the rabbit. Invest. Ophthalmol., 1975, 14(11), 872-875.
57. Silverberg, G.D.; Harbury, C.B.; Rubenstein, E. A physiological sealant for cerebrospinal fluid leaks. J. Neurosurg., 1977, 46(2), 215-219.
58. Kimura, A.; Ogata, H.; Yazawa, M.; Watanabe, N.; Mori, T.; Nakajima, T. The effects of platelet-rich plasma on cutaneous incisional wound healing in rats. J. Dermatol. Sci., 2005, 40(3), 205-208.
59. Molina-Minano, F.; Lopez-Jornet, P.; Camacho-Alonso, F.; Vicente-Ortega, V. The use of plasma rich in growth factors on wound healing in the skin: experimental study in rabbits. Int. Wound J., 2009, 6(2), 145-148.
60. Cieslik-Bielecka, A. Estimation of an influence the autogenous growth factors on postoperative wound healing processes in animals and patients with double mandibular fracture, and patients with chronic wounds. Habilitation work. Medical University of Silesia, 2010, 6, 1-164.
61. Yoshida, H.; Fujita, S.; Nishida, M.; Iizuka, T. Angiogenesis in the human temporomandibular joint studied by immunohistochemistry for CD34 antigen. J. Oral Pathol. Med., 1999, 28(7), 289-292.
62. Monteiro, S.O.; Lepage, O.M.; Theoret, C.L. Effects of plateletrich plasma on the repair of wounds on the distal aspect of the forelimb in horses. Am. J. Vet. Res., 2009, 70(2), 277-282.
63. Kim, J.H.; Park, C.; Park, H.M. Curative effect of autologous platelet-rich plasma on a large cutaneous lesion in a dog. Vet. Dermatol., 2009, 20(2), 123-126.
64. Menetrey, J.; Kasemkijwattana, C.; Day, C.S.; Bosch, P.; Vogt, M.; Fu, F.H.; Moreland, M.S.; Huard, J. Growth factors improve muscle healing in vivo. J. Bone Joint Surg. Br., 2000, 82(1), 131-137.
65. Zymek, P.; Bujak, M.; Chatila, K.; Cieslak, A.; Thakker, G.; Entman, M.L.; Frangogiannis, N.G. The role of platelet-derived growth factor signaling in healing myocardial infarcts. J. Am. Coll. Cardiol., 2006, 48(11), 2315-2323.
66. Lindeboom, J.A.; Mathura, K.R.; Aartman, I.H.; Kroon, F.H.; Milstein, D.M.; Ince, C. Influence of the application of plateletenriched plasma in oral mucosal wound healing. Clin. Oral Implants Res., 2007, 18(1), 133-139.
67. Lowery, G.L.; Kulkarni, S.; Pennisi, A.E. Use of autologous growth factors in lumbar spinal fusion. Bone, 1999, 25(2 Suppl), 47S-50S.
68. Khalafi, R.S.; Bradford, D.W.; Wilson, M.G. Topical application of autologous blood products during surgical closure following a coronary artery bypass graft. Eur. J. Cardiothorac. Surg., 2008, 34(2), 360-364.
69. Cervelli, V.; Gentile, P.; Scioli, M.G.; Grimaldi, M.; Casciani, C.U.; Spagnoli, L.G.; Orlandi, A. Application of platelet-rich plasma in plastic surgery: clinical and in vitro evaluation. Tissue Eng. Part C Methods, 2009, 15(4), 625-634.
70. Crovetti, G.; Martinelli, G.; Issi, M.; Barone, M.; Guizzardi, M.; Campanati, B.; Moroni, M.; Carabelli, A. Platelet gel for healing cutaneous chronic wounds. Transfus. Apher. Sci., 2004, 30(2), 145-151.
71. Jones, B.M.; Grover, R. Early postoperative efficacy of fibrin glue in face lifts: a prospective randomized trial. Plast. Reconstr. Surg., 2007, 119(1), 433-434.
72. Marchac, D.; Greensmith, A.L. Early postoperative efficacy of fibrin glue in face lifts: a prospective randomized trial. Plast. Reconstr. Surg., 2005, 115(3), 911-916.
73. Por, Y.C.; Shi, L.; Samuel, M.; Song, C.; Yeow, V.K. Use of tissue sealants in face-lifts: a metaanalysis. Aesthetic Plast. Surg., 2009, 33(3), 336-339.
74. Fischer, L.J.; McIlhenny, S.; Tulenko, T.; Golesorkhi, N.; Zhang, P.; Larson, R.; Lombardi, J.; Shapiro, I.; DiMuzio, P.J. Endothelial differentiation of adipose-derived stem cells: effects of endothelial cell growth supplement and shear force. J. Surg. Res., 2009, 152(1), 157-166.
75. Cervelli, V.; Gentile, P.; Grimaldi, M. Regenerative surgery: use of fat grafting combined with platelet-rich plasma for chronic lowerextremity ulcers. Aesthetic Plast. Surg., 2009, 33(3), 340-345.
76. Choukroun, J.; Simonpieri, A.; Del Corso, M.; Mazor, Z.; Sammartino, G.; Dohan Ehrenfest, D.M. Controlling systematic perioperative anaerobic contamination during sinus-lift procedures by using metronidazole: an innovative approach. Implant Dent., 2008, 17(3), 257-270.
77. Beidler, S.K.; Douillet, C.D.; Berndt, D.F.; Keagy, B.A.; Rich, P.B.; Marston, W.A. Inflammatory cytokine levels in chronic venous insufficiency ulcer tissue before and after compression therapy. J. Vasc. Surg., 2009, 49(4), 1013-1020.
78. Murphy, M.A.; Joyce, W.P.; Condron, C.; Bouchier-Hayes, D. A reduction in serum cytokine levels parallels healing of venous ulcers in patients undergoing compression therapy. Eur. J. Vasc. Endovasc. Surg., 2002, 23(4), 349-352.
79. Toriseva, M.; Kahari, V.M. Proteinases in cutaneous wound healing. Cell. Mol. Life Sci., 2009, 66(2), 203-224.
80. Pieper, B.; Templin, T.N.; Kirsner, R.S.; Birk, T.J. Impact of injection drug use on distribution and severity of chronic venous disorders. Wound Repair Regen., 2009, 17(4), 485-491.
81. Bahebeck, J.; Bedimo, R.; Eyenga, V.; Kouamfack, C.; Kingue, T.; Nierenet, M.; Sosso, M. The management of musculoskeletal infection in HIV carriers. Acta Orthop. Belg., 2004, 70(4), 355-360.
82. Salama, C.; Finch, D.; Bottone, E.J. Fusospirochetosis causing necrotic oral ulcers in patients with HIV infection. Oral Surg. Oral Med. Oral Pathol. Oral Radiol. Endod., 2004, 98(3), 321-323.
83. Driver, V.R.; Hanft, J.; Fylling, C.P.; Beriou, J.M.; Autologel Diabetic Foot Ulcer Study, G. A prospective, randomized, controlled trial of autologous platelet-rich plasma gel for the treatment of diabetic foot ulcers. Ostomy Wound Manage., 2006, 52(6), 68-70, 72, 74 passim.
84. Pollak, A.N. Use of negative pressure wound therapy with reticulated open cell foam for lower extremity trauma. J. Orthop. Trauma, 2008, 22(10 Suppl), S142-145.
85. Yazar, S.; Lin, C.H.; Wei, F.C. One-stage reconstruction of composite bone and soft-tissue defects in traumatic lower extremities. Plast. Reconstr. Surg., 2004, 114(6), 1457-1466.
86. Bielecki, T.; Gazdzik, T.S. Percutaneous injection of autologous platelet-rich gel in a patient with an infected nonunion of the tibia. A case report and review of the literature. J. Orthop. Trauma Surg. Relat. Res., 2007, 2(6), 69-72.
87. Yuan, T.; Zhang, C.; Zeng, B. Treatment of chronic femoral osteomyelitis with platelet-rich plasma (PRP): a case report. Transfus. Apher. Sci., 2008, 38(2), 167-173.
88. Guo, Y.; Qiu, J.; Zhang, C. Follow-up study on platelet-rich plasma in repairing chronic wound nonunion of lower limbs in 47 cases. Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi, 2008, 22(11), 1301-1305.
89. Kazakos, K.; Lyras, D.N.; Verettas, D.; Tilkeridis, K.; Tryfonidis, M. The use of autologous PRP gel as an aid in the management of acute trauma wounds. Injury, 2009, 40(8), 801-805.
90. Marquez-de-Aracena, R.; Montero-de-Espinosa, I.; Munoz, M.; Pereira, G. Subconjunctival application of plasma platelet concentrate in the treatment of ocular burns. Preliminary results. Arch. Soc. Esp. Oftalmol., 2007, 82(8), 475-481.
91. Dohan, D.M.; Choukroun, J.; Diss, A.; Dohan, S.L.; Dohan, A.J.; Mouhyi, J.; Gogly, B. Platelet-rich fibrin (PRF): a secondgeneration platelet concentrate. Part II: platelet-related biologic features. Oral Surg. Oral Med. Oral Pathol. Oral Radiol. Endod., 2006, 101(3), e45-50.
92. Dohan, D.M.; Choukroun, J.; Diss, A.; Dohan, S.L.; Dohan, A.J.; Mouhyi, J.; Gogly, B. Platelet-rich fibrin (PRF): a secondgeneration platelet concentrate. Part III: leucocyte activation: a new feature for platelet concentrates? Oral Surg. Oral Med. Oral Pathol. Oral Radiol. Endod., 2006, 101(3), e51-55.
93. Dohan Ehrenfest, D.M.; de Peppo, G.M.; Doglioli, P.; Sammartino, G. Slow release of growth factors and thrombospondin-1 in Choukroun's platelet-rich fibrin (PRF): a gold standard to achieve for all surgical platelet concentrates technologies. Growth Factors, 2009, 27(1), 63-69.
94. Dohan Ehrenfest, D.M. How to optimize the preparation of Leukocyte-and Platelet-Rich Fibrin (L-PRF, Choukroun's technique) clots and membranes: introducing the PRF Box. Oral Surg. Oral Med. Oral Pathol. Oral Radiol. Endod., 2010, 110(3), 275-278.
95. Su, C.Y.; Kuo, Y.P.; Tseng, Y.H.; Su, C.H.; Burnouf, T. In vitro release of growth factors from platelet-rich fibrin (PRF): a proposal to optimize the clinical applications of PRF. Oral Surg. Oral Med. Oral Pathol. Oral Radiol. Endod., 2009, 108(1), 56-61.
96. He, L.; Lin, Y.; Hu, X.; Zhang, Y.; Wu, H. A comparative study of platelet-rich fibrin (PRF) and platelet-rich plasma (PRP) on the effect of proliferation and differentiation of rat osteoblasts in vitro. Oral Surg. Oral Med. Oral Pathol. Oral Radiol. Endod., 2009, 108(5), 707-713.
97. Dohan Ehrenfest, D.M.; Del Corso, M.; Inchingolo, F.; Sammartino, G.; Charrier, J.B. Platelet-Rich Plasma (PRP) and Platelet-Rich Fibrin (PRF) in human cell cultures: growth factor release and contradictory results. Oral Surg. Oral Med. Oral Pathol. Oral Radiol. Endod., 2010, 110(4), 418-421.
98. Dohan Ehrenfest, D.M.; Diss, A.; Odin, G.; Doglioli, P.; Hippolyte, M.P.; Charrier, J.B. In vitro effects of Choukroun's PRF (plateletrich fibrin) on human gingival fibroblasts, dermal prekeratinocytes, preadipocytes, and maxillofacial osteoblasts in primary cultures. Oral Surg. Oral Med. Oral Pathol. Oral Radiol. Endod., 2009, 108(3), 341-352.
99. Dohan Ehrenfest, D.M.; Doglioli, P.; de Peppo, G.M.; Del Corso, M.; Charrier, J.B. Choukroun's platelet-rich fibrin (PRF) stimulates in vitro proliferation and differentiation of human oral bone mesenchymal stem cell in a dose-dependent way. Arch. Oral Biol., 2010, 55(3), 185-194.
100. Dohan Ehrenfest, D.M.; Del Corso, M.; Inchingolo, F.; Charrier, J.B. Selecting a relevant in vitro cell model for testing and comparing the effects of a Choukroun's Platelet-Rich Fibrin (PRF) membrane and a platelet-rich plasma (PRP) gel: tricks and traps. Oral Surg. Oral Med. Oral Pathol. Oral Radiol. Endod., 2010, 110(4), 409-411.
101. Choukroun, J.I.; Braccini, F.; Diss, A.; Giordano, G.; Doglioli, P.; Dohan, D.M. Influence of platelet rich fibrin (PRF) on proliferation of human preadipocytes and tympanic keratinocytes: A new opportunity in facial lipostructure (Coleman's technique) and tympanoplasty? Rev. Laryngol. Otol. Rhinol. (Bord.), 2007, 128(1-2), 27-32.
102. Choukroun, J.; Diss, A.; Simonpieri, A.; Girard, M.O.; Schoeffler, C.; Dohan, S.L.; Dohan, A.J.; Mouhyi, J.; Dohan, D.M. Plateletrich fibrin (PRF): a second-generation platelet concentrate. Part IV: clinical effects on tissue healing. Oral Surg. Oral Med. Oral Pathol. Oral Radiol. Endod., 2006, 101(3), e56-60.
103. Choukroun, J.; Diss, A.; Simonpieri, A.; Girard, M.O.; Schoeffler, C.; Dohan, S.L.; Dohan, A.J.; Mouhyi, J.; Dohan, D.M. Plateletrich fibrin (PRF): a second-generation platelet concentrate. Part V: histologic evaluations of PRF effects on bone allograft maturation in sinus lift. Oral Surg. Oral Med. Oral Pathol. Oral Radiol. Endod., 2006, 101(3), 299-303.
104. Braccini, F.; Tardivet, L.; Dohan Ehrenfest, D.M. The relevance of Choukroun's Platelet-Rich Fibrin (PRF) during middle ear surgery: preliminary results. Rev. Laryngol. Otol. Rhinol. (Bord.), 2009, 130(3), 175-180.
105. Simonpieri, A.; Del Corso, M.; Sammartino, G.; Dohan Ehrenfest, D.M. The relevance of Choukroun's platelet-rich fibrin and metronidazole during complex maxillary rehabilitations using bone allograft. Part I: a new grafting protocol. Implant Dent., 2009, 18(2), 102-111.
106. Simonpieri, A.; Del Corso, M.; Sammartino, G.; Dohan Ehrenfest, D.M. The relevance of Choukroun's platelet-rich fibrin and metronidazole during complex maxillary rehabilitations using bone allograft. Part II: implant surgery, prosthodontics, and survival. Implant Dent., 2009, 18(3), 220-229.
107. Mazor, Z.; Horowitz, R.A.; Del Corso, M.; Prasad, H.S.; Rohrer, M.D.; Dohan Ehrenfest, D.M. Sinus floor augmentation with simultaneous implant placement using Choukroun's platelet-rich fibrin as the sole grafting material: a radiologic and histologic study at 6 months. J. Periodontol., 2009, 80(12), 2056-2064.
108. Jang, E.S.; Park, J.W.; Kweon, H.; Lee, K.G.; Kang, S.W.; Baek, D.H.; Choi, J.Y.; Kim, S.G. Restoration of peri-implant defects in immediate implant installations by Choukroun platelet-rich fibrin and silk fibroin powder combination graft. Oral Surg. Oral Med. Oral Pathol. Oral Radiol. Endod., 2010, 109(6), 831-836.
109. Lee, E.H.; Kim, J.Y.; Kweon, H.Y.; Jo, Y.Y.; Min, S.K.; Park, Y.W.; Choi, J.Y.; Kim, S.G. A combination graft of lowmolecular-weight silk fibroin with Choukroun platelet-rich fibrin for rabbit calvarial defect. Oral Surg. Oral Med. Oral Pathol. Oral Radiol. Endod., 2010, 109(5), e33-38.
110. Dohan Ehrenfest, D.M.; Lemo, N.; Jimbo, R.; Sammartino, G. Selecting a relevant animal model for testing the in vivo effects of choukroun's platelet-rich fibrin (PRF): rabbit tricks and traps. Oral Surg. Oral Med. Oral Pathol. Oral Radiol. Endod., 2010, 110(4), 413-416.
111. Simonpieri, A.; Choukroun, J.; Del Corso, M.; Sammartino, G.; Dohan Ehrenfest, D.M. Simultaneous sinus-lift and implantation using microthreaded implants and leukocyte-and platelet-rich fibrin as sole grafting material: a six-year experience. Implant Dent., 2011, 20(1), 2-12.
112. Del Corso, M.; Sammartino, G.; Dohan Ehrenfest, D.M. Re: "Clinical evaluation of a modified coronally advanced flap alone or in combination with a platelet-rich fibrin membrane for the treatment of adjacent multiple gingival recessions: a 6-month study". J. Periodontol., 2009, 80(11), 1694-1697.
113. Braccini, F.; Dohan, D.M. The relevance of Choukroun's platelet rich fibrin (PRF) during facial aesthetic lipostructure (Coleman's technique): preliminary results. Rev. Laryngol. Otol. Rhinol. (Bord.), 2007, 128(4), 255-260.
114. Charrier, J.B.; Monteil, J.P.; Albert, S.; Collon, S.; Bobin, S.; Dohan Ehrenfest, D.M. Relevance of choukroun's platelet-rich fibrin (PRF) and SMAS flap in primary reconstruction after superficial or subtotal parotidectomy in patients with focal pleiomorphic adenoma: a new technique. Rev. Laryngol. Otol. Rhinol. (Bord.), 2008, 129(4-5), 313-318.
115. O'Connell, S.M.; Impeduglia, T.; Hessler, K.; Wang, X.J.; Carroll, R.J.; Dardik, H. Autologous platelet-rich fibrin matrix as cell therapy in the healing of chronic lower-extremity ulcers. Wound Repair Regen., 2008, 16(6), 749-756.